Distinguishing Autoimmune Hepatitis From Steatohepatitis in Adolescents With Obesity and Positive Screening Alanine Aminotransferase
- PMID: 37200725
- PMCID: PMC10187841
- DOI: 10.1097/PG9.0000000000000292
Distinguishing Autoimmune Hepatitis From Steatohepatitis in Adolescents With Obesity and Positive Screening Alanine Aminotransferase
Abstract
Screening children with obesity for nonalcoholic fatty liver disease leads to identification of elevated alanine aminotransferase (ALT) and is a common cause for referral to pediatric gastroenterology. Guidelines recommend that children with positive screening ALT be evaluated for causes of ALT elevation beyond nonalcoholic fatty liver disease. One clinical challenge is that autoantibodies can be present in patients with obesity and thus may or may not represent autoimmune hepatitis. This case series highlights the importance of a comprehensive evaluation to reach an accurate diagnosis.
Keywords: liver histology; nonalcoholic fatty liver disease; ultrasound.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Schwimmer JB, Deutsch R, Kahen T, et al. . Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–1393. - PubMed
 
- 
    - Deneau M, Jensen MK, Holmen J, et al. . Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology. 2013;58:1392–1400. - PubMed
 
- 
    - Radhakrishnan KR, Alkhouri N, Worley S, et al. . Autoimmune hepatitis in children—impact of cirrhosis at presentation on natural history and long-term outcome. Dig Liver Dis. 2010;42:724–728. - PubMed
 
- 
    - Vos MB, Abrams SH, Barlow S, et al. . NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64:319–334. - PMC - PubMed
 
- 
    - Khayat A, Vitola B. Prevalence and clinical significance of autoantibodies in children with overweight and obesity with nonalcoholic fatty liver disease. J Pediatr. 2021;239:155–160. - PubMed
 
Publication types
LinkOut - more resources
- Full Text Sources
 
        